Gena L. Ashe, Chief Legal Officer and Corporate Secretary of Anterix Inc., filed an amended Form 4/A on September 11, 2026, disclosing a series of transactions in Anterix common stock on September 8, 2026.

Key Highlights

  • Option exercise: Ashe exercised a stock option for 6,833 shares of common stock at an exercise price of $34.96 per share on September 8, 2026.
  • Cashless exercise: According to the filing, the exercise price was paid on a cashless basis, with the issuer withholding 2,769 shares to cover the exercise price and income tax withholding obligations.
  • Open market sales: Ashe disposed of 293 shares and 4,064 shares of common stock, both at $85.44 per share, on September 8, 2026.
  • Remaining beneficial ownership: Following all reported transactions, Ashe directly held 9,238 shares of Anterix common stock.
  • Remaining derivative position: Ashe continued to hold 35,658 stock options (right to buy) directly following the reported transactions.
  • Vesting schedule: The filing states the exercised option vests in three equal annual installments, with 1/3 vesting on May 20, 2026, and the remainder in two equal annual installments thereafter, expiring May 20, 2035.

Anterix CLO Ashe Exercises Options and Sells Shares on September 8, 2026

According to the amended filing, Gena L. Ashe, serving as Chief Legal Officer and Corporate Secretary of Anterix Inc. (NASDAQ:ATEX), reported four distinct transactions involving the company's common stock, all occurring on September 8, 2026. The filing is an amendment to an original Form 4 also dated September 8, 2026.

The filing discloses that Ashe exercised a stock option covering 6,833 shares at a conversion price of $34.96 per share on a cashless basis. As a result, the issuer withheld an aggregate of 2,769 shares "to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option." The filing notes that "the withholding of shares referenced here does not involve an open market sale of stock." In addition to the option-related transactions, Ashe disposed of 293 shares and 4,064 shares of common stock in separate transactions, both at a price of $85.44 per share. Following all reported transactions, Ashe's direct beneficial ownership of Anterix common stock stood at 9,238 shares.

In Table II of the filing, the remaining stock option balance is reported at 35,658 options directly held following the exercise. The option's expiration date is listed as May 20, 2035. The filing was signed by Gena L. Ashe on September 9, 2026.

What Was Disclosed

The amended filing reports a cashless stock option exercise of 6,833 shares at $34.96, the withholding of 2,769 shares for taxes and exercise costs, and the open market sale of a combined 4,357 shares at $85.44, leaving Ashe with 9,238 directly held common shares.